+467.0%
MRNA vs HBM
+97.2%
+369.8%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | HBM | Excess | Alpha |
|---|---|---|---|---|
| 1D | +5.4% | -0.5% | +5.9% | +5.6% |
| 7D | -1.1% | -3.3% | +2.2% | -0.1% |
| 30D | +126.1% | -4.8% | +130.9% | +129.6% |
| 3M | +190.0% | -0.4% | +190.5% | +187.7% |
| 6M | +157.2% | +17.9% | +139.4% | +140.0% |
| YTD | +388.2% | +33.7% | +354.5% | +329.5% |
| 1Y | +467.0% | +95.6% | +371.4% | +331.4% |
| All | +467.0% | +97.2% | +369.8% | +331.4% |
Cumulative growth
Daily Returns
Daily percentage return beside HBM.
Daily Out/Under-Performance
Portfolio return minus HBM return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × HBM return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded HBM wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling